Document is current
Any future updates will be listed below
-
Authors
Baranda, Joaquina C.
Mohyuddin, Ghulam Rehman
Bur, Andrés M.
Shnayder, Yelizaveta
Sweeney, Kyle R.
Kakarala, Kiran
Prouty, Megan
Pathak, Harsh
Puri, Rajni
Mitra, Amrita
Madan, Rashna
Forrest, M. Laird
Huang, Aric
Weir, Scott
Godwin, Andrew K.
Alhakamy, Nabil A.
Griffin, J. Daniel
Berkland, Cory J.
-
Funding
Funding for this research was provided by:
NIGMS (P20 GM130423)
NCI (P30CA168524)
- License Information
-
More Information
Article History
Received: 1 December 2022
Accepted: 14 February 2023
First Online: 27 February 2023
Declarations
:
: This study involving consenting participants was approved by the Institutional Review Board at the University of Kansas Comprehensive Cancer Center.
: Not applicable.
: C.J.B., N.A.A., and J.D.G. are co-founders of Kinimmune, Inc. AKG is a co-founder of Sinochips Diagnostics, serves as a scientific advisory board member to Biovica, Clara Biotech, and Sinochips Diagnostics, and receives research funding from Predicine and VITRAC Therapeutics”.
